These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted? Standl E, Schnell O. Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474 [No Abstract] [Full Text] [Related]
18. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide]. Rupprecht E, König E, Limmer J. Pol Tyg Lek; 1993 Apr 10; 48 Suppl 1():31-2. PubMed ID: 8516203 [No Abstract] [Full Text] [Related]